rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-12-5
|
pubmed:abstractText |
To develop a clinically relevant genotypic resistance score for boosted atazanavir (ATV) in protease inhibitor-experienced patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0269-9370
|
pubmed:author |
pubmed-author:CalvezVincentV,
pubmed-author:FlandrePhilippeP,
pubmed-author:GünthardHuldrych FHF,
pubmed-author:HirschHans HHH,
pubmed-author:MarcelinAnne-GenevièveAG,
pubmed-author:MasquelierBernardB,
pubmed-author:PerrinLucL,
pubmed-author:PeytavinGillesG,
pubmed-author:Swiss HIV Cohort Study,
pubmed-author:VoraSamirS,
pubmed-author:YerlySabineS,
pubmed-author:ZinkernagelAnneliesA
|
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16327317-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16327317-Cohort Studies,
pubmed-meshheading:16327317-Drug Resistance, Viral,
pubmed-meshheading:16327317-Female,
pubmed-meshheading:16327317-Genotype,
pubmed-meshheading:16327317-HIV Infections,
pubmed-meshheading:16327317-HIV Protease Inhibitors,
pubmed-meshheading:16327317-HIV-1,
pubmed-meshheading:16327317-Humans,
pubmed-meshheading:16327317-Male,
pubmed-meshheading:16327317-Mutation,
pubmed-meshheading:16327317-Oligopeptides,
pubmed-meshheading:16327317-Pyridines,
pubmed-meshheading:16327317-RNA, Viral,
pubmed-meshheading:16327317-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16327317-Ritonavir,
pubmed-meshheading:16327317-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.
|
pubmed:affiliation |
Laboratory of Virology, Geneva University Hospital, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|